Article
Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays.
JCO precision oncology - 1 May 2023
Krumm Niklas, Khasnavis Nithisha S, Radke Marc, Banda Kalyan, Davies Helen R, Pennil Christopher, McLean Kathryn, Paulson Vera A, Konnick Eric Q, Johnson Winslow C, Huff Grogan, Nik-Zainal Serena, Swisher Elizabeth M, Lockwood Christina M, Salipante Stephen J
Abstract excerpt
PURPOSE: Homologous recombination DNA repair deficiency (HRD) is a therapeutic biomarker for sensitivity to platinum and poly(ADP-ribose) polymerase inhibitor therapies in breast and ovarian cancers. Several molecular phenotypes and diagnostic strategies have been developed to assess HRD; however, their clinical implementation remains both technically challenging and methodologically unstandardized. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
